In the latest installment of Kuala Lumpur news, the healthcare and e-commerce sectors have shown vibrant activity with significant developments from DC Healthcare, LYC Healthcare, and Synergy House Berhad. DC Healthcare unveiled its Q4 FY2023 results with a revenue of RM17.6 million, largely from aesthetic services, and announced new branches to fuel growth. LYC Healthcare reported a strong Q3 FY2024 performance, with revenue reaching RM35.9 million, driven by its nutraceutical business and strategic Singapore investments. Adding to the corporate achievements, Synergy House Berhad, a leader in cross-border e-commerce and furniture export, reported a remarkable FY2023 finish with a revenue of RM270.2 million and a 63.25 per cent increase in PAT, highlighting significant growth in both B2C and B2B sectors, particularly in the United States, the United Kingdom, and emerging markets. These reports underline the dynamic nature of both the healthcare and e-commerce industries in Kuala Lumpur, showcasing companies’ resilience, strategic planning, and commitment to expanding their market presence and enhancing shareholder value, thereby promising an optimistic outlook for stakeholders across these vibrant sectors.
Synergy House Surges Ahead
Synergy House Berhad, a leading cross-border e-commerce and furniture export company, announced a strong finish for FY2023 with a revenue of RM270.2 million and a profit after tax (PAT) increase of 63.25 per cent.
The company reported significant growth in both its B2C and B2B sectors, with a notable performance in the United States, the United Kingdom, and emerging markets.
The B2C segment’s revenue surged by 145.37 per cent, highlighting Synergy House’s strategic focus on expanding its online presence and entering new markets.
In recognition of its stellar performance, the company declared a second interim dividend of 0.6 cent per share.
Executive Directors, Tan Eu Tah and Teh Yee Luen, emphasized the company’s commitment to growth and shareholder value, leveraging technology and artificial intelligence to enhance operations and customer engagement.
With a market capitalization of RM432.5 million and a positive outlook from RHB Investment Bank, Synergy House is poised for further expansion and innovation in the global furniture e-commerce market.
DC Healthcare Achieves Growth, Plans Expansion
DC Healthcare Holdings Berhad, a leading provider of aesthetic medical services, announced its financial results for Q4 FY2023, ending the year with significant achievements.
The Group reported a Q4 revenue of RM17.6 million, mainly from aesthetic services, marking a substantial part of its annual revenue of RM67.8 million.
Despite one-off IPO costs, the adjusted Profit Before Tax stood at RM8.9 million, reflecting operational strength.
The year witnessed strategic expansions, including new branches in Ipoh and Taman Molek, Johor Bahru, expected to bolster future growth.
Prof. Datuk Dr. Kj. Rohaizat Bin Hj. Yon has joined as medical advisor, bringing valuable expertise.
With the aesthetic medicine market projected to grow significantly, DC Healthcare is well-positioned for continued success and industry leadership.
LYC Healthcare Posts Strong Q3 Growth
LYC Healthcare Berhad announced significant revenue growth in Q3 FY2024, reaching RM35.9 million, up from RM23.5 million in the same period last year.
This increase is largely attributed to its expanding nutraceutical business and strategic lease modifications.
The Group successfully reduced its Loss Before Tax to RM1.2 million from RM1.8 million in Q3 FY2023, indicating effective operational strategies.
Significant contributions came from the Malaysian segment, with revenue hitting RM24.0 million, and the Singapore operations, which generated RM11.9 million in revenue and a profit before tax of RM0.8 million.
Overall, LYC Healthcare’s revenue for the first nine months of FY2024 was RM95.0 million, a marked improvement from RM66.6 million in the previous year.
The Group’s operational enhancements and strategic investments, especially in the healthcare sector in Singapore, have set a solid foundation for future profitability and growth.
Sui Dong Hoe, Managing Director and Group CEO, highlighted the positive trajectory towards profitability, driven by strategic acquisitions and plans for listing entities under LYC Medicare (Singapore) Pte Ltd on the SGX Catalist board.
These moves are crucial for reinforcing LYC Healthcare’s market presence and delivering value to stakeholders.
Media & PR: editor@dailystraits.com. Copyright 2021–Present DailyStraits.com. All rights reserved.